2015
DOI: 10.1016/j.bioorg.2015.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
16
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 48 publications
(16 citation statements)
references
References 40 publications
0
16
0
Order By: Relevance
“…The derivative 10a has potent inhibitory activity against EeAChE (IC 50 of 0.092 μM) and moderate for EqBuChE (IC 50 of 0.234 μM), βA antiaggregation properties (67.8% inhibition at 20 μM) and also has Cu 2+ and Fe 2+ metal chelating ability due to its amide linkage (Xie, Wang, Li, Yang, & Kong, ). Further, the coumarin moiety linked with thiourea, (compound 10b ) was found the most potent AChE inhibitor with IC 50 value of 0.04 μM (Saeed et al, ). In coumarin based MTDL derivatives ( 10c and 10d ), the 6‐ and 7‐positions of coumarin are linked with alkyl spacer of different lengths with terminal diethyl amino group which leads to human AChE inhibition at nanomolar concentration (IC 50 of 11.7 nM and 12.9 nM, respectively) along with significant inhibitory activity toward βA 42 self‐aggregation around 60% and promising neuroprotective behavior, which makes this compounds a potential disease‐modifying agent (Saeed et al, ).…”
Section: Flavonoidsmentioning
confidence: 99%
See 1 more Smart Citation
“…The derivative 10a has potent inhibitory activity against EeAChE (IC 50 of 0.092 μM) and moderate for EqBuChE (IC 50 of 0.234 μM), βA antiaggregation properties (67.8% inhibition at 20 μM) and also has Cu 2+ and Fe 2+ metal chelating ability due to its amide linkage (Xie, Wang, Li, Yang, & Kong, ). Further, the coumarin moiety linked with thiourea, (compound 10b ) was found the most potent AChE inhibitor with IC 50 value of 0.04 μM (Saeed et al, ). In coumarin based MTDL derivatives ( 10c and 10d ), the 6‐ and 7‐positions of coumarin are linked with alkyl spacer of different lengths with terminal diethyl amino group which leads to human AChE inhibition at nanomolar concentration (IC 50 of 11.7 nM and 12.9 nM, respectively) along with significant inhibitory activity toward βA 42 self‐aggregation around 60% and promising neuroprotective behavior, which makes this compounds a potential disease‐modifying agent (Saeed et al, ).…”
Section: Flavonoidsmentioning
confidence: 99%
“…Further, the coumarin moiety linked with thiourea, (compound 10b ) was found the most potent AChE inhibitor with IC 50 value of 0.04 μM (Saeed et al, ). In coumarin based MTDL derivatives ( 10c and 10d ), the 6‐ and 7‐positions of coumarin are linked with alkyl spacer of different lengths with terminal diethyl amino group which leads to human AChE inhibition at nanomolar concentration (IC 50 of 11.7 nM and 12.9 nM, respectively) along with significant inhibitory activity toward βA 42 self‐aggregation around 60% and promising neuroprotective behavior, which makes this compounds a potential disease‐modifying agent (Saeed et al, ). Further, when coumarin is attached to the dithiocarbamate moiety, then compound 10e shows the best inhibitory activity toward hAChE (IC 50 of 0.027 μM) and also acts as a βA antiaggregator (40.19% at 25 μM) (Jiang et al, ).…”
Section: Flavonoidsmentioning
confidence: 99%
“…8 Substitutions on the benzopyrone ring influence the chemical, structural 9 and biological properties of coumarins. [10][11][12] Moreover, a large degree of structural and chemical diversity is reached by introducing different heteroatoms in the 1-and/or 2-positions of the 1-benzopyran-2one group. In particular, 2-thiocoumarins are accessible from the corresponding coumarine by using an equimolar amount of p-methoxyphenylthionophosphine sulfide dimer (Lawesson's Reagent) as sulfur-transfer reagent.…”
Section: Introductionmentioning
confidence: 99%
“…/ γ C 7 -C 6 -C 8 -C 13 (58); γ S-C-O-C(42) 527 vw 521 m 532(0.1) a'' / τ C 8 -C 8 -C 10 -C 5(12); γ S-C-O-C (52); γ C 3 -C 4 -C 10 -C 12 (36) 523(1) a' / δ C 5 -C 10 -C 9 (45);δ O-C 9 -C 8(28); ν CH 3 -Py (27) 497 vw 492 w 500(1) a' / τ H-C 13 -C 7 -C 8 (83); ν CH 3 -Py (18) 458 w 464(9) a' / δ C 2 -C 3 -O (38); δ C 7 -C 8 -C 9(36) ; ν CH 3 -Ph (25); 435 w 445(7) a'' / γ O-C 10 -C 8 -C 9 (85); γ S-C-O-C (14) 384 s 386(5) a' / νC=S (60); δ C-O-C (40) 337(0.07) a' / ρ C-CH 3 -Ph (52); ρ C-CH 3 Py (48) 274(0.2) a'' / τ C 4 -C 3 -C 2 -O (62); τ ring Ph (48) 258(1) a' / δ C 2 -C 3 -C 4 (73); δ C 5 -C 6 -C 7 (27) 247(0.0004) a'' / γ CH 3 -Ph(83); γ O-C 10 -C 8 -C 9 (16) 198(1) a'' / ρ CH 3 ring Py (84); τ C 3 -C 2 -O-C 9 (16) 197 m 190(0.4) a' / δ CS (59); δ C-H ring Ph (41) 158(0.001) a'' / τ H-C 12 -C 4 -C 3 (36); τ C 3 -C 2 -O-C 9 (64) 98(2) a'' / τ C 2 -O-C 9 -C 10 (85); τ C 3 -C 2 -O-C 9 (15) 73(0.2) a' / τ S-C-O-C (12); τ ring Ph (87) 34(0.2)…”
mentioning
confidence: 99%
“…) . Taking into account these facts and our continued interest in developing useful bioactive molecules , as well as coumarin hybrids , it was considered worthwhile to undertake the synthesis of a library of bioactive coumarin–triazolothiadiazine hybrids and evaluation of their ALP inhibition, anticancer, and antileishmanial potential. In addition, molecular docking studies of these compounds have also been carried out to gain further insights into the biological properties.…”
Section: Introductionmentioning
confidence: 99%